Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2011-04-12
2011-04-12
Sullivan, Daniel M (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S579000
Reexamination Certificate
active
07923579
ABSTRACT:
The present invention relates to compounds and methods for inhibiting histone deacetylase enzymatic activity. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit histone deacetylases (IIDACs), and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, and also central nervous system diseases. It further deals with processes for preparing said compounds.
REFERENCES:
patent: 4829080 (1989-05-01), Maignan et al.
patent: 5567721 (1996-10-01), Bernardon et al.
patent: 0 382 076 (1990-08-01), None
patent: 97/33856 (1997-09-01), None
patent: 01/38322 (2001-05-01), None
patent: 01/56358 (2001-08-01), None
patent: 02/22577 (2002-03-01), None
patent: 02/098363 (2002-12-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al. Advanced Drug Delivery Reviews 2001, 48, 3-26, abstract.
International Search Report of PCT/IB2004/004334, mailed Apr. 22, 2005.
Zacheis et al., “Heteroarotinoids Inhibit Head and Neck Cancer Cell Lines in Vitro and in Vivo Through Both RAR and RXR Retinoic Acid Receptors”, Journal of Medicinal Chemistry, 1999, vol. 42, No. 21, pp. 4434-4445, XP002278654.
Lavoie et al., “Design and Synthesis of a Novel Class of Histone Deacetylase Inhibitors”, Bioorganic & Medicinal Chemistry Letters, vol. 11, No. 21, 2001, pp. 2847-2850, XP002954135.
Beausoleil Eric
Leblond Bertrand
Brooks Clinton
ExonHit Therapeutics S.A.
Nixon & Vanderhye P.C.
Sullivan Daniel M
LandOfFree
Tricyclic hydroxamate and benzamide derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic hydroxamate and benzamide derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic hydroxamate and benzamide derivatives,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691197